New study: does less invasive prostate treatment preserve quality of life?

NCT ID NCT06945172

Not yet recruiting Symptom relief Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare how men with intermediate-risk prostate cancer feel about their quality of life after either total prostate removal (surgery) or a less invasive treatment called focal HIFU (high-intensity focused ultrasound). About 100 sexually active men aged 40-75 will answer questionnaires 6, 12, and 24 months after treatment. The goal is to see which approach better preserves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this trial shows that focal HIFU leads to better quality of life than total prostatectomy, it could help men with prostate cancer choose a less invasive treatment option.
What could go wrong: This is a small, early-stage study (102 participants) that only measures quality of life, not cancer control. It may not show a clear difference, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAVORABLE INTERMEDIATE-RISK LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Clinique La Croix du Sud

Quint-Fonsegrives, 31130, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.